Hanseatic Management Services Inc Tg Therapeutics, Inc. Transaction History

Hanseatic Management Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 05, 2021	SELL	$21.78 - $40.45 $5,967 - $11,083	-274 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$18.49 - $27.24 $1,756 - $2,587	95 Added 53.07%	274 $7,000
Q1 2020 Apr 22, 2020	BUY	$7.14 - $15.99 $1,278 - $2,862	179 New	179 $2,000
Q3 2018 Nov 14, 2018	SELL	$5.15 - $14.0 $587 - $1,596	-114 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$8.7 - $16.8 $991 - $1,915	114 New	114 $2,000

354

90.2M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.81B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.